GO:0006226 dUMP biosynthetic process: Genes & Methods

dUMP biosynthetic process (GO:0006226) is defined as the chemical reactions and pathways resulting in the formation of deoxyuridine monophosphate (2'-deoxyuridine 5'-phosphate), a key intermediate in nucleotide metabolism. This process supplies the substrate for thymidylate synthase, which converts dUMP to dTMP, the nucleotide required for DNA replication and repair [3,4]. Because dUMP levels directly affect thymidylate availability, dysregulation of this pathway can lead to imbalanced nucleotide pools, uracil misincorporation into DNA, and increased mutagenesis [1,5]. Researchers study dUMP biosynthesis to understand how cells maintain deoxynucleotide triphosphate (dNTP) homeostasis and how perturbations contribute to diseases such as cancer and metabolic disorders [1,4]. The pathway intersects with pyrimidine salvage and de novo synthesis, and its enzymes are targets of widely used chemotherapeutic agents including 5-fluorouracil and its derivatives [3,4]. Recent work has revealed that dCMP deaminase DCTD and E3 ligase TOPORS modulate dUMP-related cytotoxicity of decitabine, underscoring the importance of post-translational regulation in this pathway. In addition, base excision repair proteins such as UNG2 and APE1 function in replication foci to remove uracil from DNA, linking dUMP metabolism to genome maintenance. This article synthesizes current knowledge on the enzymes, regulation, and disease relevance of dUMP biosynthetic process, and outlines experimental strategies for its study.

In simple terms, dUMP biosynthetic process (GO:0006226) is the set of biochemical steps that make dUMP, a nucleotide used as the starting material for building thymine in DNA. According to QuickGO, it encompasses the chemical reactions and pathways resulting in the formation of dUMP (2'-deoxyuridine 5'-phosphate). This process includes both direct synthesis from dCMP or dUTP and salvage-like reactions that generate dUMP, and it is essential for providing the substrate for thymidylate synthase in the thymidylate synthesis cycle [3,4].

dUMP biosynthetic process is central to nucleotide metabolism because it supplies dUMP for thymidylate synthase, the enzyme that produces dTMP and is targeted by fluoropyrimidine drugs such as 5-fluorouracil [3,4]. Perturbations in this pathway can cause dNTP pool imbalances, uracil misincorporation into DNA, and increased mutation rates, which are relevant to cancer development and chemotherapy response [1,5]. Understanding how dUMP is generated and regulated provides insights into mechanisms of drug resistance and opportunities for therapeutic intervention [1,4].

The following genes and proteins are experimentally implicated in dUMP biosynthetic process and its regulation, based on published literature.

dUMP biosynthetic process is regulated at multiple levels. DCTD activity is allosterically controlled by dCTP (activator) and dTTP (inhibitor), ensuring balanced pyrimidine pools. TYMS expression is cell-cycle dependent and can be inhibited by 5-fluorouracil, which forms a stable ternary complex with the enzyme and 5,10-methylenetetrahydrofolate [3,4]. Post-translational modification by SUMO, mediated by TOPORS, affects DCTD and modulates decitabine cytotoxicity. Additionally, base excision repair proteins UNG2 and APE1 are recruited to replication foci to handle uracil misincorporation when dUMP/dUTP pools are imbalanced. These regulatory mechanisms collectively maintain dNTP homeostasis and genome stability.

Alterations in dUMP biosynthetic process enzymes affect response to fluoropyrimidine drugs. Mutations in TYMS can confer resistance to 5-fluorodeoxyuridine, a thymidylate synthase inhibitor used in cancer therapy. DCTD expression levels influence decitabine cytotoxicity, and its regulation by TOPORS-mediated SUMOylation modulates drug sensitivity. These findings suggest that dUMP pathway components are potential biomarkers for chemotherapy response.

Imbalanced dUMP/dUTP pools lead to uracil misincorporation into DNA, which is processed by base excision repair proteins UNG2 and APE1 at replication foci. Defects in this repair pathway can result in mutations and genomic instability, contributing to cancer predisposition and other diseases.

Thymidylate synthase requires 5,10-methylenetetrahydrofolate, linking dUMP biosynthesis to one-carbon metabolism. Perturbations in folate metabolism can affect dTMP synthesis and DNA replication, with implications for developmental disorders and anemia.

Enzyme activities of DCTD, DUT, TYMS, and TMPK can be measured using radiolabeled substrates and HPLC separation of nucleotides [1,3,6]. These assays provide direct kinetic parameters and are useful for testing inhibitors.

Knockout, point mutation, and knock-in cell models enable causal testing of genes in dUMP biosynthesis [1,4]. For example, DCTD knockout cells show altered decitabine sensitivity, and TYMS point mutants confer 5-FU resistance [1,4].

Liquid chromatography-mass spectrometry (LC-MS) allows quantification of dUMP, dTMP, dUTP, and other nucleotides in cell extracts [1,5]. This method is essential for assessing pathway flux and pool imbalances.

Fluorescently tagged UNG2 and APE1 can be visualized at replication foci to study base excision repair in real time. This approach links dUMP metabolism to DNA repair dynamics.

Researchers studying dUMP biosynthetic process-related genes often need to determine whether a candidate gene is causally involved in nucleotide metabolism, drug response, or genome stability. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models for such investigations.

dUMP biosynthetic process (GO:0006226) is a fundamental metabolic pathway that supplies the nucleotide precursor for thymidylate synthase, influencing DNA synthesis, genome stability, and chemotherapy response [3,4]. Its enzymes, including DCTD, DUT, TYMS, and TMPK, are subject to complex regulation and are implicated in cancer and drug resistance [1,4,5,6]. Continued research using CRISPR-engineered models and advanced biochemical methods will further elucidate the pathway's roles in health and disease.